UnknownNCT04630782

Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Singapore General Hospital
Principal Investigator
Andrea Low
Singapore General Hospital
Intervention
PET-MRI scan(diagnostic_test)
Enrollment
70 enrolled
Eligibility
21-99 years · All sexes
Timeline
2020 – 2023

Study locations (5)

Collaborators

National University Hospital, Singapore · Tan Tock Seng Hospital · Changi General Hospital · Sengkang General Hospital · National University of Singapore · Nanyang Technological University · Duke-NUS Graduate Medical School

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04630782 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials